Coping with serum screening for Down syndrome when the results is given as a numeric value

Area of Science:

• Maternal-Fetal Medicine
• Reproductive Health
• Medical Psychology

Background:

• Second-trimester biochemical screening is standard for Down syndrome risk assessment.
• Current methods often provide numerical risk values, which may impact patient anxiety.
• Understanding the psychological effects of numerical risk reporting is crucial for patient care.

Purpose of the Study:

• To assess maternal anxiety levels in response to numerical risk reporting during Down syndrome screening.
• To investigate the correlation between changes in risk estimates and anxiety scores.
• To evaluate the impact of numerical risk reporting on decisions regarding invasive procedures.

Main Methods:

• Forty-six pregnant women completed the State-Trait Anxiety Inventory (STAI) at two time points: study recruitment and after receiving biochemical screening results.
• Biochemical screening results were communicated as numerical risk values (1/x).
• Changes in risk estimates were compared with baseline maternal age-calculated risk.

Main Results:

• Maternal anxiety (STAI scores) significantly increased in women whose Down syndrome risk estimate rose post-screening.
• A significant correlation was found between the change in risk estimate and the change in anxiety levels.
• Women with a negative test but increased risk and anxiety were more likely to opt for amniocentesis.

Conclusions:

• Communicating Down syndrome screening results as numerical values, even for 'negative' tests, can induce anxiety in some pregnant women.
• This anxiety may lead to increased requests for invasive diagnostic procedures such as amniocentesis.
• Healthcare providers should consider the psychological impact of numerical risk reporting in prenatal screening counseling.